{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T01:07:21Z","timestamp":1774314441777,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,12]]},"DOI":"10.7759\/cureus.101391","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T22:29:37Z","timestamp":1768256977000},"source":"Crossref","is-referenced-by-count":1,"title":["Lisinopril-Induced Angioedema Triggered by Tattoo Cellulitis and Acute Kidney Injury: A Case Report"],"prefix":"10.7759","author":[{"given":"Mechal","family":"Zedan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Howard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Preston","family":"Foryt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarilate","family":"Aroriode","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.32075","article-title":"A comprehensive review of bradykinin-induced angioedema versus histamine-induced angioedema in the emergency department","volume":"14","author":"Jayasinghe M","year":"2022","unstructured":"Jayasinghe M, Caldera D, Prathiraja O, et al.. A comprehensive review of bradykinin-induced angioedema versus histamine-induced angioedema in the emergency department. Cureus. 2022, 14:e32075. 10.7759\/cureus.32075","journal-title":"Cureus"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.109.134197","article-title":"Dipeptidyl peptidase-IV inhibitor use associated with increased risk of ACE inhibitor-associated angioedema","volume":"54","author":"Brown NJ","year":"2009","unstructured":"Brown NJ, Byiers S, Carr D, Maldonado M, Warner BA. Dipeptidyl peptidase-IV inhibitor use associated with increased risk of ACE inhibitor-associated angioedema. Hypertension. 2009, 54:516-23. 10.1161\/HYPERTENSIONAHA.109.134197","journal-title":"Hypertension"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.60852","article-title":"Angiotensin-converting enzyme (ACE) inhibitor-induced angioedema in an African American male with coronavirus disease 2019 (COVID-19)","volume":"16","author":"Bresler RM","year":"2024","unstructured":"Bresler RM, Whelan J. Angiotensin-converting enzyme (ACE) inhibitor-induced angioedema in an African American male with coronavirus disease 2019 (COVID-19). Cureus. 2024, 16:e60852. 10.7759\/cureus.60852","journal-title":"Cureus"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.106081","article-title":"ACE inhibitor-mediated angioedema","volume":"78","author":"Montinaro V","year":"2020","unstructured":"Montinaro V, Cicardi M. ACE inhibitor-mediated angioedema. Int Immunopharmacol. 2020, 78:106081. 10.1016\/j.intimp.2019.106081","journal-title":"Int Immunopharmacol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-018-0859-x","article-title":"ACE inhibitor-induced angioedema: a review","volume":"20","author":"Kostis WJ","year":"2018","unstructured":"Kostis WJ, Shetty M, Chowdhury YS, Kostis JB. ACE inhibitor-induced angioedema: a review. Curr Hypertens Rep. 2018, 20:55. 10.1007\/s11906-018-0859-x","journal-title":"Curr Hypertens Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0702783","article-title":"Stimulation of bradykinin B2-receptors on endothelial cells induces relaxation and contraction in porcine basilar artery in vitro","volume":"128","author":"Miyamoto A","year":"1999","unstructured":"Miyamoto A, Ishiguro S, Nishio A. Stimulation of bradykinin B2-receptors on endothelial cells induces relaxation and contraction in porcine basilar artery in vitro. Br J Pharmacol. 1999, 128:241-7. 10.1038\/sj.bjp.0702783","journal-title":"Br J Pharmacol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/falgy.2023.1263432","article-title":"Pathophysiology of bradykinin and histamine mediated angioedema","volume":"4","author":"Lima H","year":"2023","unstructured":"Lima H, Zheng J, Wong D, Waserman S, Sussman GL. Pathophysiology of bradykinin and histamine mediated angioedema. Front Allergy. 2023, 4:1263432. 10.3389\/falgy.2023.1263432","journal-title":"Front Allergy"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-6175.2002.01509.x","article-title":"Current concepts of pharmacotherapy in hypertension: ACE inhibitor-related angioedema: can angiotensin-receptor blockers be safely used?","volume":"4","author":"Sica DA","year":"2002","unstructured":"Sica DA, Black HR. Current concepts of pharmacotherapy in hypertension: ACE inhibitor-related angioedema: can angiotensin-receptor blockers be safely used?. J Clin Hypertens (Greenwich). 2002, 4:375-80. 10.1111\/j.1524-6175.2002.01509.x","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2015-212891","article-title":"Life-threatening ACE inhibitor-induced angio-oedema successfully treated with icatibant: a bradykinin receptor antagonist","volume":"2015","author":"Ostenfeld S","year":"2015","unstructured":"Ostenfeld S, Bygum A, Rasmussen ER. Life-threatening ACE inhibitor-induced angio-oedema successfully treated with icatibant: a bradykinin receptor antagonist. BMJ Case Rep. 2015, 2015:10.1136\/bcr-2015-212891","journal-title":"BMJ Case Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00639","article-title":"Complement activation in inflammatory skin diseases","volume":"9","author":"Giang J","year":"2018","unstructured":"Giang J, Seelen MA, van Doorn MB, Rissmann R, Prens EP, Damman J. Complement activation in inflammatory skin diseases. Front Immunol. 2018, 9:639. 10.3389\/fimmu.2018.00639","journal-title":"Front Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14209","article-title":"Hereditary angioedema: the plasma contact system out of control","volume":"16","author":"De Maat S","year":"2018","unstructured":"De Maat S, Hofman ZL, Maas C. Hereditary angioedema: the plasma contact system out of control. J Thromb Haemost. 2018, 16:1674-85. 10.1111\/jth.14209","journal-title":"J Thromb Haemost"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.80a.12073","article-title":"Recognizing and managing hereditary angioedema","volume":"80","author":"Tse K","year":"2013","unstructured":"Tse K, Zuraw BL. Recognizing and managing hereditary angioedema. Cleve Clin J Med. 2013, 80:297-308. 10.3949\/ccjm.80a.12073","journal-title":"Cleve Clin J Med"},{"key":"ref13","doi-asserted-by":"crossref","DOI":"10.1001\/archderm.1997.03890440040006","article-title":"Examination of baseline levels of carboxypeptidase N and complement components as potential predictors of angioedema associated with the use of an angiotensin-converting enzyme inhibitor","volume":"133","author":"Sigler C","year":"1997","unstructured":"Sigler C, Annis K, Cooper K, Haber H, Van deCarr S. Examination of baseline levels of carboxypeptidase N and complement components as potential predictors of angioedema associated with the use of an angiotensin-converting enzyme inhibitor. Arch Dermatol. 1997, 133:972-5.","journal-title":"Arch Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S146757","article-title":"Acute kidney injury and infections in patients taking antihypertensive drugs: a self-controlled case series analysis","volume":"10","author":"Mansfield KE","year":"2018","unstructured":"Mansfield KE, Douglas IJ, Nitsch D, Thomas SL, Smeeth L, Tomlinson LA. Acute kidney injury and infections in patients taking antihypertensive drugs: a self-controlled case series analysis. Clin Epidemiol. 2018, 10:187-202. 10.2147\/CLEP.S146757","journal-title":"Clin Epidemiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-025-04077-4","article-title":"Molecular mechanisms and therapeutic interventions in acute kidney injury: a literature review","volume":"26","author":"He J","year":"2025","unstructured":"He J, Chen Y, Li Y, Feng Y. Molecular mechanisms and therapeutic interventions in acute kidney injury: a literature review. BMC Nephrol. 2025, 26:144. 10.1186\/s12882-025-04077-4","journal-title":"BMC Nephrol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2013.08.005","article-title":"The role of the complement system in acute kidney injury","volume":"33","author":"McCullough JW","year":"2013","unstructured":"McCullough JW, Renner B, Thurman JM. The role of the complement system in acute kidney injury. Semin Nephrol. 2013, 33:543-56. 10.1016\/j.semnephrol.2013.08.005","journal-title":"Semin Nephrol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/441872-lisinopril-induced-angioedema-triggered-by-tattoo-cellulitis-and-acute-kidney-injury-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T22:29:38Z","timestamp":1768256978000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/441872-lisinopril-induced-angioedema-triggered-by-tattoo-cellulitis-and-acute-kidney-injury-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.101391","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,12]]}}}